Home › Funds › Candriam S.C.A. › ONC

Candriam S.C.A. position in ONC

BEONE MEDICINES LTD · Health Care

Candriam S.C.A. reported holding 289,235 shares of ONC (BEONE MEDICINES LTD) in its Q3 2026 13F filing — a position valued at US$106.2M, representing 0.48% of its reported portfolio and ranking #41 among its reported holdings. Candriam S.C.A. has disclosed ONC holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

Latest position (Q3 2026)289.24K sh
Reported value held$106.23M
Portfolio Weight0.48%
First reportedQ1 2025
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Candriam S.C.A.'s ONC position evolved

Candriam S.C.A. first disclosed a stake in ONC in Q1 2025 at 285,893 shares (US$77.8M). The position peaked in Q3 2026 at 289,235 shares, worth US$106.2M. Across 7 filings, Candriam S.C.A. increased the stake 2 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 289,235 shares valued at US$106.2M. Notable position changes include a 32% increase in Q1 2026 (shares fell 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 285.89K $77.81M New
Q2 2025 280.29K $67.85M Reduce
Q3 2025 212.57K $72.42M Reduce
Q4 2025 197.26K $59.93M Reduce
Q1 2026 259.73K $77.13M Add
Q2 2026 289.74K $82.49M Add
Q3 2026 289.24K $106.23M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ONC and 13F data

ONC (BEONE MEDICINES LTD) is a Health Care company. 29 other funds we track also report a position in ONC — the largest reported positions include BAKER BROS. ADVISORS LP (US$2.51B), PRIMECAP MANAGEMENT CO/CA/ (US$1.80B), Temasek Holdings (US$241.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ONC

All ONC fund holders →

FAQ

How long has Candriam S.C.A. held ONC?

Candriam S.C.A. has disclosed ONC holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

What is Candriam S.C.A.'s current position in ONC?

As of Q3 2026, Candriam S.C.A. holds 289.24K shares of ONC (BEONE MEDICINES LTD), valued at $106.23M, representing 0.48% of its reported portfolio and ranking #41.

Has Candriam S.C.A. been buying or selling ONC?

In the latest 13F filing (Q3 2026), Candriam S.C.A. held unchanged its position in ONC. The position peaked in Q3 2026 at 289.24K shares.

Which other funds hold ONC?

Other major institutional holders of ONC include BAKER BROS. ADVISORS LP, PRIMECAP MANAGEMENT CO/CA/, Temasek Holdings, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.